California Greens Attends ECRM's Fall Retail Session
The Nutraceutical Brand Will Be Present at The Vitamin, Weight Management & Sports Nutrition Session of the Retail Conference
The ECRM conference will take place in
"We are excited to get California Greens products in front of so many leading buyers," said a company spokesperson. "Our products have been setting the gold standard for nutraceuticals around the world for years, and we look forward to expanding our presence even further in
The session takes place from
- Bellogen, an anti-aging collagen shot clinically shown to improve skin elasticity and reduce wrinkles.
- Gardy, an immunity-boosting drinkable formula that is timely as families prepare for the back-to-school season.
- Motova, a women's health supplement designed to support women's health, including PCOS management and fertility.
There are many other products that will also be presented as California Greens launches a focused initiative to grow awareness of its line of globally respected health and wellness solutions in the
About California Greens
California Greens is an internationally based company operating in the nutraceutical market since 2009. In 2015, it launched six products under its own brand, expanding from there to build a portfolio that spans skin health, immunity, women's health, and metabolic support. The company operates with a mission to develop natural, clinically tested wellness solutions that address today's most common health concerns. It is committed to combining rigorous science with premium natural ingredients to create safe, effective solutions for consumers worldwide. Learn more at c-greens.com.
California Greens
[email protected]
+1(732)266-0110
View original content:https://www.prnewswire.com/news-releases/california-greens-attends-ecrms-fall-retail-session-302547032.html
SOURCE California Greens
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026
- Laplace Announces FDA IDE Approval of TRIUMPH Pivotal Trial of Its Transcatheter Tricuspid Valve Replacement System
- EagleVision's 'Nature, Inc.' Spotlights Jeff Perry Who Saved 1,000+ Burned Trees to Help Rebuild Altadena
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share